Global funders accelerate three Bundibugyo Ebola vaccines (opens in new tab)

CEPI said it will fast-track three experimental vaccines against Bundibugyo ebolavirus, the strain driving an outbreak in the Democratic Republic of Congo and Uganda, with funding for candidates from Moderna, the International AIDS Vaccine Initiative and the University of Oxford with the Serum Institute of India. As of June 1, the DRC had reported 282 confirmed cases, including 42 confirmed deaths, and 220 suspected cases under investigation; Uganda had reported nine confirmed cases, includin...